Cargando…

Effectiveness of temozolomide for primary glioblastoma multiforme in routine clinical practice

Temozolomide has been used as a standard therapy for the treatment of newly diagnosed glioblastoma multiforme since 2005. To assess the effectiveness of temozolomide in routine clinical practice, we conducted an observational study at Maastricht University Medical Centre (MUMC). Data of patients rec...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Genugten, J. A. B., Leffers, P., Baumert, B. G., Tjon-a-Fat, H., Twijnstra, A.
Formato:	Texto
Lenguaje:	English
Publicado:	Springer US 2009
Materias:	Clinical Study - Patient Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2808536/ https://www.ncbi.nlm.nih.gov/pubmed/19582373 http://dx.doi.org/10.1007/s11060-009-9956-7

Ejemplares similares

A new schedule of fotemustine in temozolomide-pretreated patients with relapsing glioblastoma
por: Addeo, Raffaele, et al.
Publicado: (2010)

Cognitive functioning in glioblastoma patients during radiotherapy and temozolomide treatment: initial findings
por: Hilverda, Karen, et al.
Publicado: (2009)

Radiotherapy and temozolomide for newly diagnosed glioblastoma and anaplastic astrocytoma: validation of Radiation Therapy Oncology Group-Recursive Partitioning Analysis in the IMRT and temozolomide era
por: Paravati, Anthony J., et al.
Publicado: (2010)

Improved Outcomes with Intensity Modulated Radiation Therapy Combined with Temozolomide for Newly Diagnosed Glioblastoma Multiforme
por: Aherne, Noel J., et al.
Publicado: (2014)

Efficacy and safety of intratumoral thermotherapy using magnetic iron-oxide nanoparticles combined with external beam radiotherapy on patients with recurrent glioblastoma multiforme
por: Maier-Hauff, Klaus, et al.
Publicado: (2010)

Extended-schedule dose-dense temozolomide in refractory gliomas
por: Berrocal, A., et al.
Publicado: (2009)

Two phase II trials of temozolomide with interferon-α2b (pegylated and non-pegylated) in patients with recurrent glioblastoma multiforme
por: Groves, M D, et al.
Publicado: (2009)

Treatment of primary glioblastoma multiforme with cetuximab, radiotherapy and temozolomide (GERT) – phase I/II trial: study protocol
por: Combs, Stephanie E, et al.
Publicado: (2006)

Genetic variations in VEGF and VEGFR2 and glioblastoma outcome
por: Sjöström, S., et al.
Publicado: (2010)

Longitudinal MRI evidence for decreased survival among periventricular glioblastoma
por: Young, Geoffrey S., et al.
Publicado: (2010)

Impact of glycemia on survival of glioblastoma patients treated with radiation and temozolomide
por: Tieu, Minh Thi, et al.
Publicado: (2015)

Temozolomide resistance in glioblastoma multiforme
por: Lee, Sang Y.
Publicado: (2016)

Identification of diagnostic serum protein profiles of glioblastoma patients
por: Elstner, Anja, et al.
Publicado: (2010)

Treatment outcome of patients with recurrent glioblastoma multiforme: a retrospective multicenter analysis
por: van Linde, Myra E., et al.
Publicado: (2017)

Temozolomide as salvage treatment in primary brain lymphomas
por: Reni, M, et al.
Publicado: (2007)

Accelerated hyper-versus normofractionated radiochemotherapy with temozolomide in patients with glioblastoma: a multicenter retrospective analysis
por: Klement, Rainer J., et al.
Publicado: (2021)

Hypofractionated High-Dose Irradiation with Positron Emission Tomography Data for the Treatment of Glioblastoma Multiforme
por: Miwa, Kazuhiro, et al.
Publicado: (2014)

JCOG0911 INTEGRA study: a randomized screening phase II trial of interferonβ plus temozolomide in comparison with temozolomide alone for newly diagnosed glioblastoma
por: Wakabayashi, Toshihiko, et al.
Publicado: (2018)

Implementation of neuro-oncology service reconfiguration in accordance with NICE guidance provides enhanced clinical care for patients with glioblastoma multiforme
por: Guilfoyle, M R, et al.
Publicado: (2011)

Health-related quality of life, cognitive screening, and functional status in a randomized phase III trial (EF-14) of tumor treating fields with temozolomide compared to temozolomide alone in newly diagnosed glioblastoma
por: Zhu, Jay-Jiguang, et al.
Publicado: (2017)

Afatinib and radiotherapy, with or without temozolomide, in patients with newly diagnosed glioblastoma: results of a phase I trial
por: Saran, Frank, et al.
Publicado: (2021)

Incidence of first primary central nervous system tumors in California, 2001–2005
por: Brown, Monica, et al.
Publicado: (2009)

Prognostic value of TP53 expression and MGMT methylation in glioblastoma patients treated with temozolomide combined with other chemotherapies
por: Kurdi, Maher, et al.
Publicado: (2021)

Primary spinal cord tumors of childhood: effects of clinical presentation, radiographic features, and pathology on survival
por: Crawford, John R., et al.
Publicado: (2009)

Incidence of first primary central nervous system tumors in California, 2001–2005: children, adolescents and teens
por: Brown, Monica, et al.
Publicado: (2009)

Monotherapy with methotrexate for primary central nervous lymphoma has single agent activity in the absence of radiotherapy: a single institution cohort
por: Cobert, Julien, et al.
Publicado: (2009)

Comparison of ADC metrics and their association with outcome for patients with newly diagnosed glioblastoma being treated with radiation therapy, temozolomide, erlotinib and bevacizumab
por: Wen, Qiuting, et al.
Publicado: (2014)

Prospective cohort study of radiotherapy with concomitant and adjuvant temozolomide chemotherapy for glioblastoma patients with no or minimal residual enhancing tumor load after surgery
por: Stummer, Walter, et al.
Publicado: (2012)

Estimating progression-free survival in patients with glioblastoma using routinely collected data
por: Kelly, Charlotte, et al.
Publicado: (2017)

Parasitic chyluria in a 72-year-old Sierra Leonean woman: A case report
por: Adeleke, Atilola A.
Publicado: (2019)

The influence of low-grade glioma on resting state oscillatory brain activity: a magnetoencephalography study
por: Bosma, I., et al.
Publicado: (2008)

Temozolomide 3 weeks on and 1 week off as first-line therapy for recurrent glioblastoma: phase II study from gruppo italiano cooperativo di neuro-oncologia (GICNO)
por: Brandes, A A, et al.
Publicado: (2006)

Twin pregnancy in a bicornuate uterus in rural Kenya: A case report for accidental discovery and successful delivery
por: Elias, Hussein E., et al.
Publicado: (2020)

Temozolomide as Second or Third Line Treatment of Patients with Neuroendocrine Carcinomas
por: Olsen, Ingrid H., et al.
Publicado: (2012)

Zinc enhances temozolomide cytotoxicity in glioblastoma multiforme model systems
por: Toren, Amos, et al.
Publicado: (2016)

Suppressing TRAP1 sensitizes glioblastoma multiforme cells to temozolomide
por: Wang, Nan, et al.
Publicado: (2021)

Interfering with mitochondrial dynamics sensitizes glioblastoma multiforme to temozolomide chemotherapy
por: Wang, Nan, et al.
Publicado: (2021)

Surgical resection of brain metastases: the prognostic value of the graded prognostic assessment score
por: Jakola, A. S., et al.
Publicado: (2011)

Leptomeningeal disease in oligodendroglial tumors: a population-based study
por: Roldán, Gloria, et al.
Publicado: (2011)

A microcosting study of microsurgery, LINAC radiosurgery, and gamma knife radiosurgery in meningioma patients
por: Tan, Siok Swan, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_pjmjqvnohummbg6uorn70dj7h0